ExploreWatchlistsPricing
  1. JP-listed companies
  2. H.U. Group Holdings, Inc.
  3. Financials
  4. EBITDA

H.U. Group Holdings, Inc. (4544)

Market cap
¥182B
P/E ratio
25.4x
H.U. Group Holdings provides clinical testing, diagnostic equipment, and healthcare services to hospitals and medical institutions across Japan and internationally through its specialized subsidiaries.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEBITDA (Million JPY)YoY (%)
Mar 31, 202522,904+40.69%
Mar 31, 202416,280-62.03%
Mar 31, 202342,872-34.06%
Mar 31, 202265,017+73.46%
Mar 31, 202137,483+84.00%
Mar 31, 202020,371-12.72%
Mar 31, 201923,340-8.43%
Mar 31, 201825,490-33.89%
Mar 31, 201738,556+3.26%
Mar 31, 201637,337-2.30%
Mar 31, 201538,215

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat